Fingerprint
Dive into the research topics of 'Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically